NASDAQ: INNVInnovage Holding Corp Stock
$3.80-0.19 (-4.76%)
Updated Apr 25, 2024
INNV Price
$3.80
Fair Value Price
$0.97
Market Cap
$516.42M
52 Week Low
$3.80
52 Week High
$8.05
P/E
-15.83x
P/B
1.81x
P/S
1.13x
PEG
N/A
Dividend Yield
N/A
Revenue
$720.80M
Earnings
-$31.56M
Gross Margin
16.5%
Operating Margin
-4.14%
Profit Margin
-4.4%
Debt to Equity
0.81
Operating Cash Flow
-$53k
Beta
1.22
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
INNV Overview
InnovAge Holding Corp. offers services to seniors who require support to live independently in their homes and communities. It's in-home care services include skilled, unskilled, and personal care. The company also provides in-center services (primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services), meals, activities, and transportation to its centers and third-party medical appointments. InnovAge was founded in 2007 and is headquartered in Denver, CO.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how INNV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
INNV ($3.80) is overvalued by 292.71% relative to our estimate of its Fair Value price of $0.97 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
INNV ($3.80) is not significantly undervalued (292.71%) relative to our estimate of its Fair Value price of $0.97 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
INNV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more INNV due diligence checks available for Premium users.
Be the first to know about important INNV news, forecast changes, insider trades & much more!
INNV News
Valuation
INNV fair value
Fair Value of INNV stock based on Discounted Cash Flow (DCF)
Price
$3.80
Fair Value
$0.97
Overvalued by
292.71%
INNV ($3.80) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
INNV ($3.80) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
INNV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
INNV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-15.83x
Industry
-0.78x
Market
40.97x
INNV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.81x
Industry
4.54x
INNV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
INNV's financial health
Profit margin
Revenue
$188.9M
Net Income
-$3.4M
Profit Margin
-1.8%
INNV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
INNV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$534.3M
Liabilities
$231.3M
Debt to equity
0.81
INNV's short-term assets ($156.96M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
INNV's short-term assets ($156.96M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
INNV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$9.3M
Investing
-$23.1M
Financing
-$1.9M
INNV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
INNV vs Medical Care Facility Stocks
Innovage Holding Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.